Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
5.80
+0.30 (5.45%)
At close: May 22, 2026, 4:00 PM EDT
5.79
-0.01 (-0.17%)
After-hours: May 22, 2026, 6:27 PM EDT
Q32 Bio Revenue
Q32 Bio had revenue of $53.74M in the twelve months ending March 31, 2026. In the year 2025, Q32 Bio had annual revenue of $53.74M.
Revenue (ttm)
$53.74M
Revenue Growth
n/a
P/S Ratio
1.88
Revenue / Employee
$2,442,591
Employees
22
Market Cap
98.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 53.74M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | -6.65M | -9.86M | - |
| Dec 31, 2022 | 3.21M | -30.76M | -90.56% |
| Dec 31, 2021 | 33.97M | 31.27M | 1,157.25% |
| Dec 31, 2020 | 2.70M | 1.04M | 62.18% |
| Dec 31, 2019 | 1.67M | -3.66M | -68.70% |
| Dec 31, 2018 | 5.32M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionQTTB News
- 15 hours ago - Q32 Bio initiated with an Outperform at Mizuho - TheFly
- 4 days ago - Q32 Bio initiated with an Overweight at Cantor Fitzgerald - TheFly
- 17 days ago - Q32 Bio Earnings release: Q1 2026 - Filings
- 17 days ago - Q32 Bio Quarterly report: Q1 2026 - Filings
- 17 days ago - Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 18 days ago - Q32 Bio Slides: Company presentation - Filings
- 22 days ago - Q32 Bio Proxy statement: Proxy filing - Filings
- 22 days ago - Q32 Bio Proxy statement: Proxy filing - Filings